Children with the PI*ZZ genotype of alpha-1 antitrypsin deficiency may develop liver disease than can progress to cirrhosis. The American Thoracic Society (ATS) and European Respiratory Society (ERS) have listed clinical indications for alpha-1 antitrypsin testing in pediatric patients.
